End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51,700 KRW | -1.34% | -8.66% | -28.19% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
ETFs positioned on SK bioscience Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -5.07% | ||
0.04% | 15 M€ | +13.60% | ||
0.02% | 2,867 M€ | +5.89% | - | |
0.02% | 454 M€ | +4.02% | - | |
0.02% | 153 M€ | +3.74% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.61% | - | |
0.01% | 7 M€ | +5.36% | - | |
0.00% | 45 M€ | -.--% | - | |
0.00% | 34 M€ | +7.50% | - | |
0.00% | 306 M€ | +5.07% | - | |
0.00% | 39 M€ | +5.00% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.19% | 2.87B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- A302440 Stock
- Funds and ETFs SK bioscience Co.,Ltd.